Literature DB >> 27664247

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

J Klastersky1, J de Naurois2, K Rolston3, B Rapoport4, G Maschmeyer5, M Aapro6, J Herrstedt7.   

Abstract

Entities:  

Year:  2016        PMID： 27664247     DOI： 10.1093/annonc/mdw325

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  136 in total

1.  Role of urine studies in asymptomatic febrile neutropenic patients presenting to the emergency department.

Authors:  Hady Zgheib; Aline El Zakhem; Cynthia Wakil; Mohamad Ali Cheaito; Rola Cheaito; Antoine Finianos; Ralphe Bou Chebl; Rima Kaddoura; Nader Al Souky; Imad El Majzoub
Journal:  World J Emerg Med       Date:  2021

2.  The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas.

Authors:  Xiao Jun Wang; Denise Yun Ting Goh; Sreemanee Raaj Dorajoo; Alexandre Chan
Journal:  Support Care Cancer       Date:  2017-04-11       Impact factor: 3.603

3.  Febrile neutropenia in adjuvant and neoadjuvant chemotherapy for breast cancer: a retrospective study in routine clinical practice from a single institution.

Authors:  Joy Bacrie; Marc Laurans; Pauline Iorio; Emmanuelle Fourme; Anne Béthune Volters; Laurence Bozec; Florence Lerebours; Coraline Dubot; Okba Bensaoula; Bilel Benzidane; Jean-Yves Pierga; Delphine Lefeuvre
Journal:  Support Care Cancer       Date:  2018-05-31       Impact factor: 3.603

4.  Management and Preventive Measures for Febrile Neutropenia.

Authors:  Austin J Lucas; Jacqueline L Olin; Megan D Coleman
Journal:  P T       Date:  2018-04

5.  Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.

Authors:  Christa Koenig; Christine Schneider; Jessica E Morgan; Roland A Ammann; Lillian Sung; Bob Phillips
Journal:  Support Care Cancer       Date:  2019-07-01       Impact factor: 3.603

6.  Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.

Authors:  Brian Chen; Sumimasa Nagai; James O Armitage; Bartlett Witherspoon; Chadi Nabhan; Ashley C Godwin; Y Tony Yang; Anuhya Kommalapati; Sri Harsha Tella; Carlo DeAngelis; Dennis W Raisch; Oliver Sartor; William J Hrushesky; Paul S Ray; Paul R Yarnold; Bryan L Love; LeAnn B Norris; Kevin Knopf; Laura Bobolts; Joshua Riente; Stefano Luminari; Robert C Kane; Shamia Hoque; Charles L Bennett
Journal:  Oncologist       Date:  2019-03-06

7.  Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriales infection: are they the same in neutropenic and non-neutropenic patients?

Authors:  Filippo Lagi; Giampaolo Corti
Journal:  Intern Emerg Med       Date:  2019-02-08       Impact factor: 3.397

8.  Antimicrobial Stewardship in Hematological Patients at the intensive care unit: a global cross-sectional survey from the Nine-i Investigators Network.

Authors:  Jordi Rello; Cristina Sarda; Djamel Mokart; Kostoula Arvaniti; Murat Akova; Alexis Tabah; Elie Azoulay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-09       Impact factor: 3.267

9.  Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae infection causing septic shock in cancer patients with chemotherapy-induced febrile neutropenia.

Authors:  Youn-Jung Kim; Sung Min Jung; Jihoon Kang; Seung Mok Ryoo; Chang Hwan Sohn; Dong-Woo Seo; Kyoung Soo Lim; Jin Won Huh; Sung-Han Kim; Won Young Kim
Journal:  Intern Emerg Med       Date:  2019-01-01       Impact factor: 3.397

10.  A cohort study on protocol-based nurse-led out-patient management of post-chemotherapy low-risk febrile neutropenia.

Authors:  Fiona Lim Mei Ying; Maria Choy Yin Ping; Macy Tong; Elaine Yim Pik Yan; Tracy Lui Siu Yee; Lam Yuk Ting; Anita Lo Wing Sim; Lui Cheuk Yu; Bosco Lam Hoi Shiu; Ashley Cheng Chi Kin
Journal:  Support Care Cancer       Date:  2018-03-20       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.